Novel transglutaminase 2 inhibitor and use thereof
AssigneeMd Biolab Co., Ltd.
InventorsSang Woo KIM, Hyun Cheol CHUNG, Eun Yi CHO, Ye Rin JO, Hyeon Joo KIM, Byeong Hak MOON, Yong Chul KIM, Jin Su BAE, Ga Ram KIM, Soo Youl KIM
Life of this patent
Estimating the term…
Abstract
The present invention relates to a series of novel benzoimidazole derivatives and their use.
Claims8
A compound represented by Formula 1 or a pharmaceutically acceptable salt thereof:
- wherein in Formula 1, R1 to R5 are each independently hydrogen, halogen, cyano, nitro, amino, carboxyl, or carbamoyl, except that R1 to R5 are all hydrogen.
A pharmaceutical composition for preventing or treating transglutaminase 2-related diseases, the composition comprising a compound represented by Formula 1 or a pharmaceutically acceptable salt thereof:
- wherein in Formula 1, R1 to R5 are each independently hydrogen, halogen, cyano, nitro, amino, carboxyl, or carbamoyl.
A transglutaminase 2 inhibitory composition comprising a compound represented by Formula 1 or a pharmaceutically acceptable salt thereof:
- wherein in Formula 1, R1 to R5 are each independently hydrogen, halogen, cyano, nitro, amino, carboxyl, or carbamoyl.
Dependencies are inferred from the claim text.